Literature DB >> 9337636

Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide.

C J Chu1, F Y Lee, S S Wang, R H Lu, Y T Tsai, H C Lin, M C Hou, C C Chan, S D Lee.   

Abstract

1. Hyperdynamic circulation observed in portal hypertensive states is characterized by generalized vasodilation, increased cardiac index and increased systemic and regional blood flows. Endotoxin, tumour necrosis factor-alpha (TNF-alpha) and nitric oxide (NO) have been reported to be involved in the pathogenesis of hyperdynamic circulation, but the interactions between endotoxin, TNF-alpha and NO in cirrhotic rats with ascites have never been specifically addressed. 2. This study was designed to determine systemic and portal haemodynamics and plasma levels of endotoxin, TNF-alpha and nitrate/nitrite in cirrhotic rats with ascites and investigate the relationships between these substances. 3. Plasma concentrations of endotoxin, TNF-alpha and nitrate/nitrite (an index of NO production) were determined in 25 cirrhotic rats with ascites and 17 control rats using the Limulus assay, ELISA and a colorimetric assay respectively. In addition, haemodynamic studies were performed in another ten cirrhotic rats with ascites and ten control rats. 4. Cirrhotic rats with ascites had hyperdynamic circulation accompanied by increased plasma levels of endotoxin, TNF-alpha and nitrate/nitrite, as compared with control rats. Significant correlation existed between plasma levels of endotoxin and nitrate/ nitrite (r = 0.59, P < 0.0001) and between plasma levels of endotoxin and TNF-alpha (r = 0.63, P < 0.0001). No correlation was detected between plasma levels of TNF-alpha and nitrate/nitrite (r = 0.24, P > 0.05). 5. This study suggests that endotoxaemia developed in cirrhotic rats with ascites may stimulate NO formation directly or indirectly via cytokine cascade, and consequently participate in the development and/or maintenance of hyperdynamic circulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337636     DOI: 10.1042/cs0930219

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility.

Authors:  R Wiest; S Das; G Cadelina; G Garcia-Tsao; S Milstien; R J Groszmann
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.

Authors:  Chi-Jen Chu; Ching-Chin Hsiao; Teh-Fang Wang; Cho-Yu Chan; Fa-Yauh Lee; Full-Young Chang; Yi-Chou Chen; Hui-Chun Huang; Sun-Sang Wang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

4.  Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients.

Authors:  Georgios N Kalambokis; Athanasia Mouzaki; Maria Rodi; Konstantinos Pappas; Panagiotis Korantzopoulos; Epameinondas V Tsianos
Journal:  Hepatol Int       Date:  2012-02-02       Impact factor: 6.047

5.  Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats.

Authors:  Matthias Froh; Lars Conzelmann; Peter Walbrun; Susanne Netter; Reiner Wiest; Michael-D Wheeler; Mark Lehnert; Takehiko Uesugi; Jurgen Scholmerich; Ronald G Thurman
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

6.  Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites.

Authors:  J Genescà; R Martí; F Rojo; F Campos; V Peribáñez; A Gónzalez; L Castells; C Ruiz-Marcellán; C Margarit; R Esteban; J Guardia; R Segura
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 7.  Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?

Authors:  Hiroshi Fukui
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  Probiotic as a novel treatment strategy against liver disease.

Authors:  Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Mohammad Reza Nourani; Soghra Khani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-02-25       Impact factor: 0.660

9.  Microbial translocation in chronic liver diseases.

Authors:  Marilia Rita Pinzone; Benedetto Maurizio Celesia; Michele Di Rosa; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Int J Microbiol       Date:  2012-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.